Jump to content

Corona Virus Disease/(SARS-CoV-2) II


Recommended Posts

UK's mutating variant a concern as it might undermine vaccines, scientist says

LONDON (Reuters) - The coronavirus variant first found in the British region of Kent is a concern because it is mutating and so could undermine the protection given by vaccines against developing COVID-19, the head of the UK’s genetic surveillance programme said.


Link to comment
Share on other sites

On 2/11/2021 at 10:36 AM, RandyH000 said:

Kent coronavirus variant set to ‘sweep world’, says UK scientist

Strain first detected in England, which may be 30 percent more lethal than other variants, has spread to more than 50 countries.



Interesting that the 


[Off topic 


No porcelain, China or Ansley. No WHO,.Elton John,.or Supertramp. 


Start a new thread, it doesn't have anything to do with topic of this thread, which is extreamly narrow for good reason.]

  • Like 1
Link to comment
Share on other sites

Coronavirus in Tanzania: The country that's rejecting the vaccine

For months Tanzania's government has insisted the country was free from Covid-19 - so there are no plans for vaccination. The BBC's Dickens Olewe has spoken to one family mourning the death of a husband and father suspected of having had the disease. The fear is that amid the denial, there are many more unacknowledged victims of this highly contagious virus.


Link to comment
Share on other sites

Music Therapy Brings Solace To COVID-19 Patients And Healers

Tom Sweitzer knows firsthand how social isolation and loneliness are real side effects of living through a pandemic — just as mental health professionals have warned. After he tested positive for the coronavirus last July and recovered from the worst of his initial symptoms, Sweitzer joined a COVID-19 support group on Facebook to help him deal with the condition's lingering effects.

As he watched people join "by the hundreds every day," he decided to start another support group where he could incorporate his skills as a music therapist.


Link to comment
Share on other sites

UK company Scancell developing vaccine to fight COVID-19 variants

A UK pharmaceutical company has joined the race to develop a COVID-19 vaccine that can fight off all variants of the virus. 

Scancell is working with researchers at the University of Nottingham to formulate a universal coronavirus vaccine, with a goal of rolling out the shots in 2022, The Telegraph reported.


Link to comment
Share on other sites

Nearly a third of US adults are undecided about the Covid-19 vaccine. Some say friends and family could sway them


Though officials and health experts say the end of the Covid-19 pandemic will rely on a large proportion of Americans being inoculated, nearly a third of US adults say they have not decided if they will get the vaccine when it is offered to them.The latest on the coronavirus pandemic and vaccines

About 31% of adults say they plan to "wait and see" how it works out for other people -- and about two-thirds of that group say they may be persuaded to get one if they're convinced it would be highly effective in preventing illness,
Link to comment
Share on other sites

Pfizer’s vaccine appears to reduce coronavirus transmission

Vaccinated people tend to carry less virus in their bodies than unvaccinated people, studies show

Researchers are getting the first real-world hints that a vaccine can curb the coronavirus’s spread, not just prevent people from getting seriously ill. 

People vaccinated with Pfizer’s shots and who still get infected with the coronavirus carry less virus in their bodies than unvaccinated people who are infected, researchers from Israel report in two separate preliminary studies posted February 8 at medRxiv.org.


Link to comment
Share on other sites

EU to Speed Approval of Variant-Modified Coronavirus Vaccines: Paper

FRANKFURT (Reuters) - The European Union will fast track approvals of coronavirus vaccines adapted to combat mutations, the bloc's Health Commissioner Stella Kyriakides said in a newspaper interview on Sunday.

"We have now decided that a vaccine that has been improved by the manufacturer on the basis of the previous vaccine to combat new mutations no longer has to go through the entire approval process," she told Bavaria's Augsburger Allgemeine.



Link to comment
Share on other sites

This topic is now closed to further replies.
  • Create New...